Gelonghui May 27 丨 Wei Xinkang (603676)(603676blockchainmonopoly.SH) AnnouncementblockchainmonopolyRecently, Yangpu Jingtai, a wholly-owned subsidiary of the company, received the "Drug Registration Certificate" for Multiple Trace Element Injection (I) approved and issued by the State Food and Drug Administration. The name of the drug is Multiple Trace Element Injection (I). According to the Drug Administration Law of the People's Republic of China and relevant regulations, after review, this product meets the relevant requirements for drug registration. Registration is approved and a drug registration certificate is issued. This product cannot be marketed until the production line passes GMP compliance inspection.

Multiple trace element injection (I) is a trace element supplement used to treat or support the basic needs of infants and children for trace elements.